ACTRN12613001208796
Not yet recruiting
Phase 4
Acute Coronary Syndrome patients and the effects of ticagrelor loading dose on level of platelet inhibition
Peter Larsen0 sites50 target enrollmentNovember 4, 2013
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Acute Coronary Syndrome
- Sponsor
- Peter Larsen
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Acute coronary syndrome
Exclusion Criteria
- •Known platelet function disorder
- •Platelet count less than 100
- •Prior administration of a P2Y12 receptor antagonist within 2 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Changes of patients with acute coronary syndrome who underwent percutaneous coronary intervention from 1997 to 2008-9JPRN-UMIN000019546Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine7,000
Completed
Phase 3
The Australian COPS trial - COlchicine in Patients with acute coronary SyndromesIschaemic heart diseaseCardiovascular - Coronary heart diseaseACTRN12615000861550St. Vincent's Hospital Melbourne800
Not yet recruiting
Not Applicable
Acute and Chronic Outcomes of Acute Coronary Syndrome Patients Treated with Percutaneous Coronary Intervention: A Multi-center Study in AomoriAcute coronary syndromeJPRN-UMIN000039797Hirosaki University Hospital4,000
Not yet recruiting
Not Applicable
Evaluation of an educational resource for cardiac secondary prevention: a randomised controlled trialAcute coronary syndromeCardiovascular - Coronary heart diseasePublic Health - Health promotion/educationACTRN12613000395730Deakin University100
Not yet recruiting
Not Applicable
Safe and effective early discharge of patients with low-risk coronary artery diseaseACTRN12613000200785Cardiology Department Eastern Health300